| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.0046 |
0.9 |